Case File №
#VI-2026-0748
Amplified Amino
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
42 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | C Okay | 4 | 5.2 | 4.8 | 5.5 | 13 Feb 2025 |
| BPC-157 | D Poor | 4 | 5.2 | 3.6 | 7.8 | 13 Feb 2025 |
| Retatrutide | E Bad | 4 | 4.2 | 2.2 | 7.0 | 13 Feb 2025 |
| AICAR | X N/A | 1 | 4.0 | 2.4 | 2.4 | 27 Feb 2025 |
| Alprostadil | X N/A | 1 | 6.2 | 6.2 | 6.2 | 7 May 2025 |
| Arimidex (Anastrozole) | X N/A | 1 | 4.0 | 3.1 | 3.1 | 28 Mar 2025 |
| Botulinum toxin | X N/A | 1 | 4.8 | 4.8 | 4.8 | 21 May 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Apr 2025 |
| Cartalax | X N/A | 1 | 4.0 | 3.8 | 3.8 | 16 Mar 2025 |
| Chonluten | X N/A | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 |
| DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | X N/A | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 |
| Dianabol Oil | X N/A | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 |
| Dihexa | X N/A | 1 | 4.0 | 3.8 | 3.8 | 28 Mar 2025 |
| Enclomiphene | X N/A | 1 | 6.6 | 6.6 | 6.6 | 13 Jun 2025 |
| Epithalon | X N/A | 1 | 5.4 | 5.4 | 5.4 | 20 Jun 2025 |
| Estradiol Cypionate | X N/A | 1 | 4.0 | 3.8 | 3.8 | 14 Jan 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 5.6 | 5.6 | 5.6 | 8 Jul 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X N/A | 1 | 4.0 | 2.8 | 2.8 | 27 Feb 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 4.8 | 4.8 | 4.8 | 8 Jul 2025 |
| HMG | X N/A | 1 | 4.4 | 4.4 | 4.4 | 28 Mar 2025 |
| Hyaluronic acid | X N/A | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 3.8 | 3.8 | 21 May 2025 |
| Masteron E (Drostanolone E) | X N/A | 1 | 4.0 | 2.1 | 2.1 | 24 Apr 2025 |
| MOTS-C | X N/A | 1 | 8.8 | 8.8 | 8.8 | 25 Apr 2025 |
| NA Selank Amidate | X N/A | 1 | 8.0 | 8.0 | 8.0 | 2 Apr 2025 |
| Oxytocin Acetate | X N/A | 1 | 5.9 | 5.9 | 5.9 | 7 May 2025 |
| P21 | X N/A | 1 | 5.2 | 5.2 | 5.2 | 9 Jun 2025 |
| Prostamax | X N/A | 1 | 4.0 | 3.9 | 3.9 | 13 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 5.3 | 5.3 | 5.3 | 17 Dec 2024 |
| Romosozumab | X N/A | 1 | 4.3 | 4.3 | 4.3 | 3 Jun 2025 |
| Selank | X N/A | 1 | 4.0 | 1.7 | 1.7 | 3 Jul 2025 |
| Semax | X N/A | 1 | 4.0 | 3.0 | 3.0 | 13 Feb 2025 |
| SNAP-8 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| Sustanon 400 | X N/A | 1 | 4.6 | 4.6 | 4.6 | 3 Jul 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 5.0 | 5.0 | 5.0 | 8 Jul 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 1 | 5.3 | 5.3 | 5.3 | 2 Jul 2025 |
| Testosterone Base Micro Raw | X N/A | 1 | 4.7 | 4.7 | 4.7 | 21 May 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 4.0 | 2.8 | 2.8 | 20 Jun 2025 |
| Tren Hex | X N/A | 1 | 5.7 | 5.7 | 5.7 | 2 Jul 2025 |
| Turinabol | X N/A | 1 | 4.7 | 4.7 | 4.7 | 2 Apr 2025 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 4.0 | 2.1 | 2.1 | 17 Dec 2024 |
Exhibit II
Evidence Log
45 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Estradiol Cypionate | 4.0 C | 100mg/ml | 86.5mg/ml | -13.5% | 95.63% | d4tnv3 | Lab D | Public |
| 24 May 2026 | MOTS-C | 9.1 A | 2mg | 2.4mg | +18.8% | 98.34% | gv8sm9 | Lab B | Public |
| 24 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.1 B | 20mg | 20.5mg | +2.3% | 98.89% | 2n0thq | Lab C | Community |
| 24 May 2026 | HMG | 4.2 C | 10mg | 10.4mg | +3.6% | 97.89% | rmajsb | Lab B | Public |
| 23 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.3 C | 30mg | 34.7mg | +15.8% | 96.05% | eyvrpl | Lab G | Public |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 20mg | 18.8mg | -5.8% | 97.89% | 2veg0a | Lab E | Public |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.4 A | 50mg | 59.1mg | +18.1% | 99.57% | 7yh9px | Lab G | Community |
| 21 May 2026 | Alprostadil | 7.0 A | 50mg | 52.3mg | +4.7% | 98.19% | a62sn2 | Lab A | Public |
| 21 May 2026 | Masteron E (Drostanolone E) | 5.7 B | 100mg/ml | 114.0mg/ml | +14.0% | 96.03% | 58rehm | Lab C | Public |
| 19 May 2026 | AICAR | 4.0 C | 10mg | 9.8mg | -2.2% | 96.68% | w3cr51 | Lab E | Community |
| 17 May 2026 | Semax | 4.6 C | 10mg | 9.3mg | -6.8% | 99.85% | 55h49a | Lab A | Community |
| 9 Jan 2026 | Enclomiphene | 6.9 A | 10mg | 9.7mg | -2.8% | 98.65% | bshn0c | Lab D | Public |
| 9 Jan 2026 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 4.0 C | 100mg/ml | 109.9mg/ml | +9.9% | 98.01% | 6abl2n | Lab A | Community |
| 9 Jan 2026 | Retatrutide 30mg Pen Kit | 4.2 C | 2mg | 1.8mg | -12.0% | 95.58% | 2eg528 | Lab B | Public |
| 9 Jan 2026 | T4 (Levothyroxine) | 5.4 B | 100mg | 86.1mg | -13.9% | 97.35% | gkspkp | Lab E | Public |
| 7 Jan 2026 | Prostamax | 4.0 C | 15mg | 14.3mg | -5.0% | 96.40% | k27ayp | Lab E | Public |
| 29 Dec 2025 | Arimidex (Anastrozole) | 4.3 C | 10mg | 10.7mg | +7.2% | 99.98% | e9a35v | Lab F | Public |
| 29 Dec 2025 | BPC157 5mg + TB500 5mg Blend | 7.2 A | 15mg | 12.8mg | -15.0% | 97.78% | cvux39 | Lab E | Public |
| 29 Dec 2025 | NA Selank Amidate | 9.2 A | 30mg | 29.2mg | -2.6% | 98.06% | onnsgg | Lab C | Community |
| 29 Dec 2025 | Turinabol | 4.4 C | 20mg | 17.5mg | -12.7% | 95.24% | kt9xby | Lab F | Public |
| 12 Dec 2025 | Cartalax | 4.0 C | 10mg | 8.7mg | -13.4% | 95.57% | roqny3 | Lab C | Community |
| 12 Dec 2025 | Dihexa | 4.0 C | 10mg | 11.9mg | +18.9% | 95.77% | da51ep | Lab G | Community |
| 12 Dec 2025 | Epithalon | 4.0 C | 15mg | 15.7mg | +5.0% | 97.07% | dfnue7 | Lab A | Public |
| 5 Dec 2025 | Dianabol Oil | 5.4 B | 250mg/ml | 278.3mg/ml | +11.3% | 97.55% | x743a1 | Lab F | Public |
| 5 Dec 2025 | Hyaluronic acid | 6.3 A | 50mg | 56.7mg | +13.5% | 97.30% | 5qdn9b | Lab E | Public |
| 14 Nov 2025 | Sustanon 400 | 5.5 B | 300mg/ml | 349.2mg/ml | +16.4% | 97.56% | 5nluk2 | Lab D | Public |
| 14 Nov 2025 | Testosterone Base Micro Raw | 4.9 C | 5g | 4.5g | -10.8% | 95.59% | nqq38k | Lab G | Public |
| 5 Nov 2025 | Chonluten | 6.7 A | 15mg | 13.4mg | -10.4% | 97.39% | fmj6vy | Lab F | Public |
| 5 Nov 2025 | Romosozumab | 4.0 C | 15mg | 13.9mg | -7.4% | 96.47% | liywwb | Lab F | Public |
| 4 Nov 2025 | Botulinum toxin | 4.2 C | 20mg | 17.5mg | -12.6% | 95.45% | dmem5a | Lab E | Public |
| 4 Nov 2025 | HGH 191AA (Somatropin) | 4.6 C | 2mg | 1.7mg | -13.0% | 95.22% | l9kewa | Lab C | Public |
| 4 Nov 2025 | Oxytocin Acetate | 4.4 C | 10mg | 11.2mg | +12.3% | 98.49% | o8m841 | Lab C | Public |
| 4 Nov 2025 | Winstrol Oil (Stanozolol) | 4.0 C | 250mg/ml | 271.5mg/ml | +8.6% | 97.78% | 5f8qcs | Lab C | Community |
| 17 Oct 2025 | P21 | 5.5 B | 5mg | 4.3mg | -13.1% | 99.36% | gc6m8a | Lab B | Public |
| 9 Oct 2025 | Selank | 4.0 C | 5mg | 5.6mg | +12.2% | 98.91% | svqg9h | Lab E | Public |
| 9 Oct 2025 | Thymosin Alpha-1 | 4.4 C | 50mg | 62.3mg | +24.6% | 97.18% | d2kt6v | Lab F | Public |
| 9 Oct 2025 | Tren Hex | 6.9 A | 200mg/ml | 230.9mg/ml | +15.5% | 95.14% | r0ji31 | Lab D | Community |
| 3 Oct 2025 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 4.1 C | 500g | 608.1g | +21.6% | 99.33% | ty7l4d | Lab B | Community |
| 3 Oct 2025 | SNAP-8 | 4.7 C | 5mg | 5.4mg | +7.9% | 98.25% | fvrw51 | Lab A | Community |
| 19 Feb 2025 | BPC-157 | 3.6 E | 10mg | 11.85mg | +18.5% | 99.19% | (no batch ID) | Lab A | VendorInvestigator |
| 19 Feb 2025 | BPC-157 | 7.8 A | 10mg | 10.31mg | +3.1% | 99.84% | (no batch ID) | Lab B | VendorInvestigator |
| 19 Feb 2025 | Semaglutide | 5.0 C | 5mg | 5.82mg | +16.4% | 99.73% | (no batch ID) | Lab B | VendorInvestigator |
| 19 Feb 2025 | Retatrutide | 4.4 D | 5mg | 6.74mg | +34.8% | 99.75% | (no batch ID) | Lab B | VendorInvestigator |
| 14 Feb 2025 | Semaglutide | 5.4 C | 5mg | 5.68mg | +13.6% | 99.73% | (no batch ID) | Lab A | VendorInvestigator |
| 14 Feb 2025 | Retatrutide | 7.0 A | 5mg | 5.4mg | +8.0% | 99.92% | (no batch ID) | Lab A | VendorInvestigator |
— END OF EVIDENCE LOG —